ArticleFrontiers in radiology2026
Outcomes of inferior vena cava filtration in lung transplant recipients.
Article in Frontiers in radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the safety, retrieval outcomes, and procedural characteristics of retrievable inferior vena cava (IVC) filters placed in lung transplant recipients with venous thromboembolism. Methods: This retrospective single-center study included adult lung transplant recipients who underwent retrievable IVC filter placement between January 2021 and April 2025. Collected variables included patient demographics, indication for filter placement, filter type and position, anticoagulation status, retrieval technique, dwell time, fluoroscopy time, radiation dose, complications, and survival. Retrieval probability over time was assessed using Kaplan-Meier analysis. Results: Ninety-five lung transplant recipients (44 men, 51 women; mean age, 60.3 years) underwent retrievable IVC filter placement. Indications included deep vein thrombosis alone in 74 patients (77.9%), combined deep vein thrombosis and pulmonary embolism in 20 (21.1%), and isolated pulmonary embolism in one (1.1%). Filters included Option Elite ( Conclusion: In this single-center retrospective cohort, retrievable IVC filters were managed in lung transplant recipients with a low complication rate and a majority undergoing retrieval during follow-up.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.